NEOS Investment Management LLC Boosts Stock Position in KKR & Co. Inc. (NYSE:KKR)

NEOS Investment Management LLC increased its stake in KKR & Co. Inc. (NYSE:KKR) by 29.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 33,015 shares of the asset manager’s stock after purchasing an additional 7,453 shares during the quarter. NEOS Investment Management LLC’s holdings in KKR & Co. Inc. were worth $4,883,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. AdvisorNet Financial Inc grew its holdings in KKR & Co. Inc. by 417.8% during the 4th quarter. AdvisorNet Financial Inc now owns 2,180 shares of the asset manager’s stock valued at $322,000 after buying an additional 1,759 shares in the last quarter. Whalen Wealth Management Inc. purchased a new position in KKR & Co. Inc. during the fourth quarter valued at approximately $667,000. Caldwell Investment Management Ltd. increased its holdings in KKR & Co. Inc. by 2.9% during the 4th quarter. Caldwell Investment Management Ltd. now owns 212,400 shares of the asset manager’s stock worth $31,477,000 after acquiring an additional 5,900 shares during the period. Jupiter Asset Management Ltd. lifted its stake in KKR & Co. Inc. by 50.9% in the 4th quarter. Jupiter Asset Management Ltd. now owns 114,184 shares of the asset manager’s stock worth $16,889,000 after purchasing an additional 38,524 shares in the last quarter. Finally, Sanctuary Advisors LLC boosted its holdings in KKR & Co. Inc. by 31.1% in the 3rd quarter. Sanctuary Advisors LLC now owns 92,741 shares of the asset manager’s stock valued at $12,110,000 after purchasing an additional 22,007 shares during the period. 76.26% of the stock is currently owned by institutional investors.

KKR & Co. Inc. Stock Down 1.5 %

KKR opened at $117.61 on Friday. KKR & Co. Inc. has a 12 month low of $91.92 and a 12 month high of $170.40. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.82. The business’s 50-day moving average price is $136.92 and its 200-day moving average price is $141.38. The company has a market cap of $104.46 billion, a P/E ratio of 35.32, a P/E/G ratio of 1.00 and a beta of 1.72.

KKR & Co. Inc. Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a $0.175 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $0.70 dividend on an annualized basis and a yield of 0.60%. KKR & Co. Inc.’s dividend payout ratio (DPR) is currently 21.02%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on KKR. Barclays lowered their price objective on KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 5th. Hsbc Global Res downgraded KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 30th. Oppenheimer upped their price objective on shares of KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an “outperform” rating in a research report on Thursday, December 12th. Morgan Stanley dropped their target price on shares of KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating for the company in a research report on Thursday, February 6th. Finally, Keefe, Bruyette & Woods decreased their price target on shares of KKR & Co. Inc. from $170.00 to $168.00 and set an “outperform” rating on the stock in a report on Monday, January 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $160.79.

Insider Buying and Selling at KKR & Co. Inc.

In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the company’s stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the completion of the transaction, the insider now directly owns 19,260,971 shares of the company’s stock, valued at approximately $634,841,604.16. This represents a 23.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 39.34% of the company’s stock.

KKR & Co. Inc. Profile

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.